TAK 661
Latest Information Update: 29 Jul 2015
At a glance
- Originator Takeda
- Class Antiasthmatics
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; Atopic dermatitis